Civic AI
Procurement intelligence
Federal contract award
IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR DELIVERY ORDER W81K00-22-P-0269 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026.
DIASORIN MOLECULAR, LLC · Department of Defense
- Value
- $139,650
- Start
- Oct 1, 2022
- End
- Sep 30, 2026
- Action date
- Jan 7, 2026
- PIID
- W81K0022P0269
- Status
- active
- NAICS
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- Place of performance
- JBSA FT SAM HOUSTON, TX
- Award type
- PURCHASE ORDER
Description
IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR DELIVERY ORDER W81K00-22-P-0269 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026.
Need modifications, related awards, and vendor peers? Open the full award workspace.